Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Economic evaluation of antenatal screening for Down Syndrome and serious congenital heart defects in Norway
Includes bibliographical references.
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Health Economics Unit
2014
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867613334329622528 |
|---|---|
| access_status_str | Open Access |
| author | Movik, Espen |
| author2 | Cleary, Susan |
| author_browse | Cleary, Susan Movik, Espen |
| author_facet | Cleary, Susan Movik, Espen |
| author_sort | Movik, Espen |
| collection | Thesis |
| description | Includes bibliographical references. |
| format | Thesis |
| id | oai:open.uct.ac.za:11427/9398 |
| institution | University of Cape Town (South Africa) |
| language | eng |
| last_indexed | 2026-06-10T12:34:28.941Z |
| license_str | Not specified — see source repository |
| provenance_str_mv | Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository |
| publishDate | 2014 |
| publishDateRange | 2014 |
| publishDateSort | 2014 |
| publisher | Health Economics Unit |
| publisherStr | Health Economics Unit |
| record_format | dspace |
| source_str | UCTD — University of Cape Town Open Access Repository |
| spelling | oai:open.uct.ac.za:11427/9398 Economic evaluation of antenatal screening for Down Syndrome and serious congenital heart defects in Norway Movik, Espen Cleary, Susan Health Economics Track Includes bibliographical references. Following recommendations laid down by a consensus conference in 1986, the policy of the Norwegian government has been to offer a routine ultrasound scan to all pregnant women at 18 weeks of gestation, i.e. in the second trimester (weeks 14-27) of pregnancy . This form of antenatal screening is also provided in other European countries, though several countries have gone further and now offer universal screening in the first trimester (weeks 1-13), between the 11th and 13th week of gestation, as well as in the second. In 2006, the Norwegian Directorate for Health contemplated a revision of its antenatal care guidelines, and in the process, sought to determine whether anexpansion of the programme to incorporate universal first trimester screening would be a rational step with regard to the anticipated extra benefits and costs. Except for a relatively small patient co-payment charge, antenatal screening is publicly financed as is the case with most other healthservices. Norway has however, a small but thriving private healthcare sector, and first trimester ultrasound scanning has been offered by private providers in recent years. The are many potential benefits of antenatal ultrasound screening and some of them are undoubtedly controversial. The information gained from a scan may, depending on its timing, assist in determining the pregnancy term, the number of foetuses in the uterus, the location of the placenta and the condition of the foetus. If the foetus is found to suffer from a particular disease, it may sometimes be treated prior to birth. Invariably however, ultrasound scanning in pregnancy is often associated with the detection of foetal anomalies or defects, such as Down syndrome, congenital heart defects or neural tube defects. The detection can in some cases lead to the pregnancy being terminated, whilst in other cases it may prepare the parents for a life with a child who may requiremore attention and care than others. This provision of information may be considered beneficial, however one may choose to act upon it, although it also invites an active decision which could induce negative feelings. On the other hand, the potential stress and anxiety involved in the screening and diagnostic process may be viewed as disadvantageous. This study will focus on two of the most important anomalies, at least in terms of the attention they are given in the literature: Down syndrome (DS) and serious congenital heart defects (SCHD). 2014-11-08T14:30:45Z 2014-11-08T14:30:45Z 2010 Master Thesis Masters MPH http://hdl.handle.net/11427/9398 eng application/pdf Health Economics Unit Faculty of Health Sciences University of Cape Town |
| spellingShingle | Health Economics Track Movik, Espen Economic evaluation of antenatal screening for Down Syndrome and serious congenital heart defects in Norway |
| thesis_degree_str | Master's |
| title | Economic evaluation of antenatal screening for Down Syndrome and serious congenital heart defects in Norway |
| title_full | Economic evaluation of antenatal screening for Down Syndrome and serious congenital heart defects in Norway |
| title_fullStr | Economic evaluation of antenatal screening for Down Syndrome and serious congenital heart defects in Norway |
| title_full_unstemmed | Economic evaluation of antenatal screening for Down Syndrome and serious congenital heart defects in Norway |
| title_short | Economic evaluation of antenatal screening for Down Syndrome and serious congenital heart defects in Norway |
| title_sort | economic evaluation of antenatal screening for down syndrome and serious congenital heart defects in norway |
| topic | Health Economics Track |
| url | http://hdl.handle.net/11427/9398 |
| work_keys_str_mv | AT movikespen economicevaluationofantenatalscreeningfordownsyndromeandseriouscongenitalheartdefectsinnorway |